Results

1–10 of 63 results for Subretinal

Subretinal Aflibercept vs Ranibizumab vs Bevacizumab in the Context of PPV: Pneumatic Displacement With Subretinal Air and tPA in Naïve Submacular Hemorrhage Due to nAMD
Matias Iglicki, MD
Annual Meeting Talks
2024
Subretinal AGTC-501 Gene Therapy for XLRP: 12-Month Interim Safety & Efficacy Results of the Randomized Controlled Multicenter Phase 2 Skyline Trial
Rajiv Anand, MD, FRCS, FASRS
Annual Meeting Talks
2024
Baseline Characteristics Associated With Catastrophic Vision Loss Due to Subretinal Hemorrhage in Patients Undergoing Treatment for Neovascular Macular Degeneration
Eric W Schneider, MD
Annual Meeting Talks
2024
Subretinal Delivery of Investigational ABBV-RGX-314 for Neovascular Age-Related Macular Degeneration: A Phase II Pharmacodynamic Study
Edward H. Wood, MD, FASRS
Annual Meeting Talks
2024
1-Year Results of a Phase 2 Pharmacodynamic Study: Subretinal Delivery of Investigational Gene Therapy ABBV-RGX-314 for Neovascular AMD
Robert L. Avery, MD
Updates from the Field
2025
Subretinal Pneumatic Displacement Without Tissue Plasminogen Activator for Submacular Hemorrhage: One-year Outcomes
Marwan Abdulaal, MD
Annual Meeting Talks
2022
Interim Subretinal Gene Therapy Safety Results in Two Phase 1/2 Open-label, Dose-Escalation Clinical Trials to Treat Achromatopsia
Lejla Vajzovic, MD, FASRS
Annual Meeting Talks
2022
Transretinal Subretinal Fluid Injection Technique for Refractory or Chronic Large Macular Holes
Gregory D Lee, MD
Annual Meeting Talks
2022
Two-Year Evaluation of Subretinal Fluid Drainage Techniques in Pars Plana Vitrectomy for Primary Rhegmatogenous Retinal Detachment (ELLIPSOID-2 Study)
Bryon McKay, MD, PhD, FRCSC
Annual Meeting Talks
2022
Retinal Detachment Repair After Inadvertent Subretinal Injection of Triamcinolone Following an Attempted Sub-Tenon Injection
On Demand Cases, Courses, and Papers
2022